FDA Approves Novel Nonopioid Treatment for Moderate-to-Severe Acute Pain

The FDA has approved suzetrigine (Journavx, Vertex Pharmaceuticals) 50 mg oral tablets as a first-in-class ...

JANUARY 31, 2025